The IC Chat

<p>Welcome to IC Chat with host Dr. Ashish Pershad. In this episode we examine the controversial role of transcatheter edge-to-edge mitral valve repair for functional mitral regurgitation, focusing on the COAPT...

<p>In this episode host Ashish Pershad reviews the ORBITA CTO randomized, double-blind, sham-controlled trial that compared CTO-PCI to a placebo procedure, explaining the rigorous design, patient selection, masking...

<p>Host Dr. Ashish Pershad introduces IC Chat’s mission to help clinicians interpret evidence-based medicine and translate trial data into everyday patient care. In this episode he appraises the CHIP-BCIS-3 randomized...

<p>In this episode of ICChat, Dr. Ashish Pershad MD MS reviews and critiques the CHAMPION‑AF trial comparing Watchman Flex left atrial appendage occlusion to DOACs for atrial fibrillation. He explains the trial design...

<p>Critical appraisal of the 6-year Evolut low risk trial data and a one on one with Steve Yakubov one of the senior authors on the paper for his take on TAVR adoption in low-risk patients</p>

<p>Appraisal of the SHORTCUT and VICTORY trials comparing IVL to CB and OPN balloons plus a bonus interview with Ajay Kirtane MD deconstructing the trials</p>

<p>A critical appraisal of the CREST 2 clinical trial 4-year outcomes comparing carotid revascularization with current medical therapy in asymptomatic patients with high grade carotid artery stenosis. </p>

<p>A critical appraisal of ENCIRCLE and a follow up interview with Encircle Co-PI David Daniels MD make for an interesting episode. </p>

<p>A Critical appraisal of dedicated TAVR valve trials for AI and a general overview of the status of AI treatment in 2025. </p>

<p>A deep dive into bicuspid aortic valve stenosis and the choice of BEV vs SEV- A propensity matched observational study critically appraised.</p>

<p>A deep dive into 2 network metanalysis looking at IVI in contemporary PCI. </p>

<p>A critical appraisal of PLATO (Ticagrelor versus Clopidogrel) and the recent controversies </p>

<p>A decades long practice of routinely tapping effusions upfront in patients with heart failure is challenged with this simple and elegantly conducted clinical trial from Denmark. The TAP IT clinical trial is...

<p>Critical appraisal of the FAME 3 Clinical Trial 5-year data presented at ACC 2025</p>

<p>A critical appraisal of the Protected TAVI trial, comparing Cerebral Embolic Protection with standard of care for routine TAVR cases.</p> <p>Bibliography:</p> <p>1. Kharbanda RK, Kennedy J, Jamal Z et al; BHF...